Akt3 overexpression in the heart results in progression from adaptive to maladaptive hypertrophy

Journal of Molecular and Cellular Cardiology

Volumn 38, Issue 2, 2005, Pages 375-385

  Taniyama, Yoshiaki ^a   Ito, Masahiro ^a   Sato, Kaori ^a   Kuester, Christoph ^b   Veit, Kerstin ^b   Tremp, Gunter ^b   Liao, Ronglih ^a   Colucci, Wilson S ^a   Ivashchenko, Yuri ^b   Walsh, Kenneth ^a   Shiojima, Ichiro ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Akt; Cardiac growth; Hypertrophy; Signaling; Transgenic

Indexed keywords

DOXORUBICIN; PROTEIN KINASE B; PROTEIN KINASE B BETA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HEART; HEART HYPERTROPHY; HEART INJURY; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; MALE; MORTALITY; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SURVIVAL;

ANIMALIA; MAMMALIA; MUS MUSCULUS;

EID: 20844439021     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2004.12.002     Document Type: Article

References (43)

1. S.R. Datta, A. Brunet, and M.E. Greenberg Cellular survival: a play in three Akts Genes Dev 13 1999 2905 2927
2. M.A. Lawlor, and D.R. Alessi PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci 114 2001 2903 2910
3. M.P. Scheid, and J.R. Woodgett PKB/AKT: functional insights from genetic models Nat Rev Mol Cell Biol 2 2001 760 768
4. I. Vivanco, and C.L. Sawyers The phosphatidylinositol 3-Kinase AKT pathway in human cancer Nat Rev Cancer 2 2002 489 501
5. I. Shiojima, and K. Walsh Role of Akt signaling in vascular homeostasis and angiogenesis Circ Res 90 2002 1243 1250
6. B.A. Hemmings Akt signaling: linking membrane events to life and death decisions Science 275 1997 628 630
7. J. Downward Mechanisms and consequences of activation of protein kinase B/Akt Curr Opin Cell Biol 10 1998 262 267
8. W.S. Chen, P.Z. Xu, K. Gottlob, M.L. Chen, K. Sokol, and T. Shiyanova Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene Genes Dev 15 2001 2203 2208
9. H. Cho, J.L. Thorvaldsen, Q. Chu, F. Feng, and M.J. Birnbaum Akt1/pkbalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice J Biol Chem 276 2001 38349 38352
10. H. Cho, J. Mu, J.K. Kim, J.L. Thorvaldsen, Q. Chu, and E.B. Crenshaw 3rd Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta) Science 292 2001 1728 1731
11. R.S. Garofalo, S.J. Orena, K. Rafidi, A.J. Torchia, J.L. Stock, and A.L. Hildebrandt Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta J Clin Invest 112 2003 197 208
12. X.D. Peng, P.Z. Xu, M.L. Chen, A. Hahn-Windgassen, J. Skeen, and J. Jacobs Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2 Genes Dev 17 2003 1352 1365
13. J. Faridi, J. Fawcett, L. Wang, and R.A. Roth Akt promotes increased mammalian cell size by stimulating protein synthesis and inhibiting protein degradation Am J Physiol Endocrinol Metab 285 2003 E964 E972
14. D. Brodbeck, M.M. Hill, and B.A. Hemmings Two splice variants of protein kinase B gamma have different regulatory capacity depending on the presence or absence of the regulatory phosphorylation site serine 472 in the carboxyl-terminal hydrophobic domain J Biol Chem 276 2001 29550 29558
15. Y. Fujio, T. Nguyen, D. Wencker, R.N. Kitsis, and K. Walsh Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart Circulation 101 2000 660 667
16. W. Miao, Z. Luo, R.N. Kitsis, and K. Walsh Intracoronary, adenovirus-mediated Akt gene transfer in heart limits infarct size following ischemia-reperfusion injury in vivo J Mol Cell Cardiol 32 2000 2397 2402
17. T. Matsui, J. Tao, F. Del Monte, K.H. Lee, L. Li, and M. Picard Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo Circulation 104 2001 330 335
18. T. Matsui, L. Li, J.C. Wu, S.A. Cook, T. Nagoshi, and M.H. Picard Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart J Biol Chem 277 2002 22896 22901
19. T. Shioi, J.R. McMullen, P.M. Kang, P.S. Douglas, T. Obata, and T.F. Franke Akt/protein kinase B promotes organ growth in transgenic mice Mol Cell Biol 22 2002 2799 2809
20. G. Condorelli, A. Drusco, G. Stassi, A. Bellacosa, R. Roncarati, and G. Iaccarino Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice Proc Natl Acad Sci USA 99 2002 12333 12338
21. Y. Taniyama, and K. Walsh Elevated myocardial Akt signaling ameliorates doxorubicin-induced congestive heart failure and promotes heart growth J Mol Cell Cardiol 34 2002 1241 1247
22. I. Shiojima, M. Yefremashvili, Z. Luo, Y. Kureishi, A. Takahashi, and J. Tao Akt signaling mediates postnatal heart growth in response to insulin and nutritional status J Biol Chem 277 2002 37670 37677
23. S.V. Naga Prasad, G. Esposito, L. Mao, W.J. Koch, and H.A. Rockman Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy J Biol Chem 275 2000 4693 4698
24. A.D. Kohn, F. Takeuchi, and R.A. Roth Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation J Biol Chem 271 1996 21920 21926
25. A. Subramaniam, W.K. Jones, J. Gulick, S. Wert, J. Neumann, and J. Robbins Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice J Biol Chem 266 1991 24613 24620
26. D.M. Weinstein, M.J. Mihm, and J.A. Bauer Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice J Pharmacol Exp Ther 294 2000 396 401
27. M. Kojima, I. Shiojima, T. Yamazaki, I. Komuro, Z. Zou, and Y. Wang Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro Circulation 89 1994 2204 2211
28. F. Sam, D.B. Sawyer, D.L. Chang, F.R. Eberli, S. Ngoy, and M. Jain Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart Am J Physiol Heart Circ Physiol 279 2000 H422 H428
29. K. Nagata, C. Ye, M. Jain, D.S. Milstone, R. Liao, and R.M. Mortensen Galpha(i2) but not Galpha(i3) is required for muscarinic inhibition of contractility and calcium currents in adult cardiomyocytes Circ Res 87 2000 903 909
30. B.D. Manning, A.R. Tee, M.N. Logsdon, J. Blenis, and L.C. Cantley Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway Mol Cell 10 2002 151 162
31. K. Inoki, Y. Li, T. Zhu, J. Wu, and K.L. Guan TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling Nat Cell Biol 4 2002 648 657
32. H. Konishi, S. Kuroda, M. Tanaka, H. Matsuzaki, Y. Ono, and K. Kameyama Molecular cloning and characterization of a new member of the RAC protein kinase family: association of the pleckstrin homology domain of three types of RAC protein kinase with protein kinase C subspecies and beta gamma subunits of G proteins Biochem Biophys Res Commun 216 1995 526 534
33. D. Brodbeck, P. Cron, and B.A. Hemmings A human protein kinase Bgamma with regulatory phosphorylation sites in the activation loop and in the C-terminal hydrophobic domain J Biol Chem 274 1999 9133 9136
34. K. Nakatani, H. Sakaue, D.A. Thompson, R.J. Weigel, and R.A. Roth Identification of a human Akt3 (protein kinase B gamma) which contains the regulatory serine phosphorylation site Biochem Biophys Res Commun 257 1999 906 910
35. S. Masure, B. Haefner, J.J. Wesselink, E. Hoefnagel, E. Mortier, and P. Verhasselt Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3 Eur J Biochem 265 1999 353 360
36. K.S. Walker, M. Deak, A. Paterson, K. Hudson, P. Cohen, and D.R. Alessi Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha Biochem J 331 1998 299 308
37. K. Nakatani, D.A. Thompson, A. Barthel, H. Sakaue, W. Liu, and R.J. Weigel Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines J Biol Chem 274 1999 21528 21532
38. P.K. Singal, and N. Iliskovic Doxorubicin-induced cardiomyopathy N Engl J Med 339 1998 900 905
39. E.L. De Beer, A.E. Bottone, and E.E. Voest Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review Eur J Pharmacol 415 2001 1 11
40. L. Wang, W. Ma, R. Markovich, J.W. Chen, and P.H. Wang Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I Circ Res 83 1998 516 522
41. O.J. Arola, A. Saraste, K. Pulkki, M. Kallajoki, M. Parvinen, and L.M. Voipio-Pulkki Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis Cancer Res 60 2000 1789 1792
42. D.L. Mann Mechanisms and models in heart failure: A combinatorial approach Circulation 100 1999 999 1008
43. L. Wei, K. Imanaka-Yoshida, L. Wang, S. Zhan, M.D. Schneider, and F.J. DeMayo Inhibition of Rho family GTPases by Rho GDP dissociation inhibitor disrupts cardiac morphogenesis and inhibits cardiomyocyte proliferation Development 129 2002 1705 1714